**Core Concept**
Porphyrias are a group of disorders resulting from defects in the biosynthesis of heme, a critical component of hemoglobin and various enzymes. Certain medications can exacerbate the condition by inducing enzymes involved in the heme biosynthetic pathway, leading to increased production of porphyrins and potentially severe symptoms. Safe medications for patients with porphyria are those that do not induce the enzymes involved in heme biosynthesis.

**Why the Correct Answer is Right**
Midazolam is a benzodiazepine that can be safely used in patients with porphyria. Unlike other benzodiazepines, midazolam does not induce the enzymes responsible for heme biosynthesis, making it a suitable option for sedation in these patients. This is due to its short half-life and lack of hepatic metabolism, which minimizes its impact on the heme biosynthetic pathway.

**Why Each Wrong Option is Incorrect**
**Option A:** Phenobarbitone is a barbiturate that induces the enzymes involved in heme biosynthesis, making it contraindicated in porphyria. It can worsen the condition by increasing the production of porphyrins.
**Option B:** Ketamine is a dissociative anesthetic that can induce the heme biosynthetic pathway, although to a lesser extent than other anesthetics. However, it is not entirely safe for use in porphyria and should be used with caution.
**Option C:** Sodium valproate is an anticonvulsant that can induce the heme biosynthetic pathway, particularly the enzyme aminolevulinic acid synthase, which is the rate-limiting step in heme biosynthesis. This makes it contraindicated in porphyria.
**Option E:** Pethidine is an opioid that can induce the heme biosynthetic pathway, particularly the enzyme aminolevulinic acid synthase. Its use in porphyria is generally avoided due to the risk of exacerbating the condition.

**Clinical Pearl / High-Yield Fact**
It is essential to note that certain medications, such as barbiturates and anticonvulsants, can exacerbate porphyria by inducing the heme biosynthetic pathway. Patients with porphyria should be carefully managed, and medications should be chosen based on their safety profile in this condition.

**Correct Answer:** D. Midazolam